Jazz Pharmaceuticals Plc (JAZZ)
241.55
+1.18
(+0.49%)
USD |
NASDAQ |
Nov 13, 16:00
241.57
+0.02
(+0.01%)
Pre-Market: 19:59
Jazz Pharmaceuticals Price to Book Value : 3.694 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.694 |
| November 12, 2026 | 3.676 |
| November 11, 2026 | 3.796 |
| November 10, 2026 | 3.753 |
| November 09, 2026 | 3.724 |
| November 06, 2026 | 3.590 |
| November 05, 2026 | 3.476 |
| November 04, 2026 | 3.588 |
| November 03, 2026 | 3.513 |
| November 02, 2026 | 3.279 |
| October 30, 2026 | 3.303 |
| October 29, 2026 | 3.178 |
| October 28, 2026 | 3.136 |
| October 27, 2026 | 3.162 |
| October 26, 2026 | 3.146 |
| October 23, 2026 | 3.272 |
| October 22, 2026 | 3.282 |
| October 21, 2026 | 3.241 |
| October 20, 2026 | 3.269 |
| October 19, 2026 | 3.187 |
| October 16, 2026 | 3.215 |
| October 15, 2026 | 3.279 |
| October 14, 2026 | 3.206 |
| October 13, 2026 | 3.217 |
| October 12, 2026 | 3.314 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.34 |
| October 08, 2026 | 3.402 |
| October 07, 2026 | 3.535 |
| October 06, 2026 | 3.538 |
| October 05, 2026 | 3.610 |
| October 02, 2026 | 3.604 |
| October 01, 2026 | 3.563 |
| September 30, 2026 | 3.540 |
| September 29, 2026 | 3.136 |
| September 28, 2026 | 3.216 |
| September 25, 2026 | 3.211 |
| September 24, 2026 | 3.189 |
| September 23, 2026 | 3.170 |
| September 22, 2026 | 3.246 |
| September 21, 2026 | 3.259 |
| September 18, 2026 | 3.249 |
| September 17, 2026 | 3.291 |
| September 16, 2026 | 3.287 |
| September 15, 2026 | 3.250 |
| September 14, 2026 | 3.318 |
| September 11, 2026 | 3.317 |
| September 10, 2026 | 3.245 |
| September 09, 2026 | 3.256 |
| September 08, 2026 | 3.240 |
| September 04, 2026 | 3.331 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| GH Research Plc | 3.647 |
| Cosmo NV | -- |
| Corcept Therapeutics, Inc. | 9.568 |
| Eli Lilly & Co. | 33.74 |
Price to Book Value Related Metrics
| PE Ratio | 81.93 |
| PS Ratio | 3.374 |
| Price to Free Cash Flow | 10.68 |
| Price | 241.55 |
| Earnings Yield | 1.22% |
| Market Cap | 15.48B |
| Operating PE Ratio | 13.62 |
| Normalized PE Ratio | 19.51 |